J Surg Oncol19 Feb 2024
Examining T2 multifocal hepatocellular carcinoma (MHCC), researchers compared liver resection (LR) and tumor ablation (TA) in a cohort of 1225 patients. Despite higher 30-day mortality with LR, 10-year overall survival favored LR over TA (27.5% vs. 14.7%). Stratified analysis revealed significant benefits in patients with…
J Gastroenterol Hepatol18 Feb 2024
A retrospective study investigated the impact of postoperative adjuvant chemotherapy (POAC) on outcomes in patients with colorectal cancer liver metastases (CRLM) undergoing simultaneous resection. After propensity score matching analysis, 478 patients were enrolled and assigned to POAC or non-POAC groups. The study found that POAC…
Gastroenterology17 Feb 2024
Cell neighborhoods within the tumor microenvironment of pancreatic ductal adenocarcinoma (PDA) play a crucial role in determining clinical outcomes. Researchers used immunohistochemistry and image analysis to study cell neighborhoods in PDA tumors from chemotherapy-naïve and chemotherapy-treated patients. They found that distinct intratumoral immune and tumor…
J Am Coll Surg17 Feb 2024
Researchers proposed a prognosis-oriented definition for borderline resectable hepatocellular carcinoma (HCC) based on a study of 221 patients. They identified risk factors for early recurrence, including serum α-fetoprotein levels ≥12 ng/ml, tumor diameters >5 cm, tumor number ≥3, and macrovascular invasion. With these criteria, they…
World J Surg17 Feb 2024
Researchers analyzed data from patients who underwent complex hepato-pancreato-biliary surgeries in Uganda, reporting that most patients were females with a median age of 50 years. The most common surgeries performed were on the bile ducts, with a high prevalence of malignancy. Despite challenges like limited…
Ann Surg16 Feb 2024
This study aimed to identify potential biomarkers for early prediction of persistent organ failure (POF) in acute pancreatitis (AP) patients. Using serum exosomal miRNAs, researchers identified a classifier comprising three miRNAs (miR-4265, 1208, 3127-5p) that demonstrated high predictive value for POF. This classifier outperformed other…
Gastrointest Endosc15 Feb 2024
Analysis of the MAUDE database reveals that the single operator cholangioscopy (SOC) system, specifically the SpyGlass DS and DS II devices, carries additional risks compared to standard endoscopic retrograde cholangiopancreatography. The study identifies 2,331 device problems reported between January 2016 and August 2023, with optical…
Ann Surg Oncol15 Feb 2024
Among patients with initially unresectable hepatocellular carcinoma (uhcc), combination therapy with transcatheter arterial chemoembolization, lenvatinib, and anti-PD-1 antibodies achieved high tumor response rates and converted some cases to resectable disease. A retrospective study compared outcomes in uhcc patients who underwent salvage surgery (sr group) versus…
Ann Surg Oncol15 Feb 2024
A study investigated the use of a fut variant-based CA19-9 tumor marker gene test to assess the outcome of pancreatic cancer surgery. The test showed that higher preoperative CA19-9 levels were associated with recurrence and mortality in patients with higher fut groups, but not in…
Ann Surg Oncol15 Feb 2024
Myosteatosis and creatinine-to-cystatin C ratio (CCR) were evaluated as prognostic biomarkers in patients with pancreatic cancer (PC) who underwent radical surgery. The study included 215 patients, and the results showed that myosteatosis and CCR ≤ 1.09 were independent risk factors associated with poor overall survival…